Winton Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69K | Buy |
+76,061
| New | +$69K | ﹤0.01% | 795 |
|
|
2021
Q4 | – | Sell |
-62,869
| Closed | -$158K | – | 1230 |
|
|
2021
Q3 | $158K | Buy |
62,869
+9,260
| +17% | +$23.3K | 0.01% | 1263 |
|
|
2021
Q2 | $153K | Buy |
53,609
+9,596
| +22% | +$27.4K | 0.01% | 1368 |
|
|
2021
Q1 | $103K | Buy |
44,013
+9,242
| +27% | +$21.6K | 0.01% | 1332 |
|
|
2020
Q4 | $61K | Sell |
34,771
-32,761
| -49% | -$57.5K | ﹤0.01% | 1282 |
|
|
2020
Q3 | $63K | Sell |
67,532
-40,748
| -38% | -$38K | ﹤0.01% | 1434 |
|
|
2020
Q2 | $94K | Sell |
108,280
-10,655
| -9% | -$9.25K | ﹤0.01% | 1405 |
|
|
2020
Q1 | $98K | Sell |
118,935
-40,416
| -25% | -$33.3K | ﹤0.01% | 1326 |
|
|
2019
Q4 | $142K | Buy |
+159,351
| New | +$142K | ﹤0.01% | 1473 |
|